Risperidone vs. Paroxetine for Panic Attacks

Stopped early · Phase 2

Conditions studied: Major Depressive Disorder With Panic Attacks, Panic Disorder

In brief

We are comparing the efficacy of Risperidone versus Paroxetine in the treatment of panic symptoms. The study hypothesis is that Risperidone will be a superior medicine for treating panic.

Key facts

Study ID

NCT00206765

Run by

Beth Israel Medical Center

People needed

90

Starts

2003-01-01

Expected to finish

2005-07-01

Last updated by the study team

2012-10-22

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females, ages 21-55.
• Ability to sign an informed consent
• Diagnosis of Panic Disorder, or MDD with Panic attacks, single episode, recurrent, or chronic
• HAM-A score >17

You may not qualify if…

• Alcohol or substance abuse within the last 6 months
• Current diagnosis of Obsessive-Compulsive Disorder
• Current diagnosis of Schizophrenia, Schizoaffective Disorder, or Bipolar Mood Disorder
• Use of antipsychotic medications over the two months preceding enrollment in the study
• Changes in antidepressant or mood stabilizer dosing over the two months preceding enrollment in the study
• Previous adverse reaction to risperidone or paroxetine.

Where it is running

• Beth Israel Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.